Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 11.35B 358M 312M 294M 267M 501M 34.25B 502M 3.52B 1.36B 17.45B 1.34B 1.31B 56.31B P/E 2026 *
9.94x
P/E 2027 * -
Enterprise Value 11.35B 358M 312M 294M 267M 501M 34.25B 502M 3.52B 1.36B 17.45B 1.34B 1.31B 56.31B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.56x
Free-Float
47.64%
Yield 2026 *
6%
Yield 2027 * -
08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/08/25 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/05/25 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
06/03/25 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
06/03/25 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
13/11/24 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
12/08/24 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
10/05/24 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/03/24 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Current month-6.62%
1 month-2.19%
3 months+0.37%
6 months-4.63%
Current year-8.22%
1 week 133
Extreme 133
135.5
1 month 132.5
Extreme 132.5
145
Current year 122
Extreme 122
154
1 year 122
Extreme 122
165
3 years 122
Extreme 122
346.5
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.643305
432.08
Manager TitleAgeSince
Chief Executive Officer - 01/02/2010
Director of Finance/CFO - 01/04/2016
President - -
Director TitleAgeSince
Chairman - 28/06/2012
Director/Board Member - 02/06/2003
Director/Board Member 66 28/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-17.79%-58.77% 357M
+1.62%-4.37%-48.39%-16.63% 73.26B
-0.26%-2.69%-12.66%-24.58% 31.5B
-0.88%-1.07% - - 12.81B
-2.12%-0.18%-20.61%-34.08% 10.51B
+7.60%+15.89%+5.02%+676.03% 2.5B
+1.59%+1.80%-40.52%-59.86% 1.34B
-3.85%-2.44% - - 973M
+2.78%+6.68%+27.99%+14.49% 956M
+2.15%+7.30%-34.21%-19.82% 892M
Average +0.87%+1.87%-17.65%+59.60% 13.51B
Weighted average by Cap. +0.74%-1.88%-34.72%-6.31%

Financials

2026 *2027 *
Net sales 4.25B 134M 117M 110M 100M 188M 12.83B 188M 1.32B 508M 6.53B 503M 492M 21.09B 4.44B 140M 122M 115M 105M 196M 13.4B 196M 1.38B 530M 6.83B 525M 514M 22.02B
Net income 1.14B 35.97M 31.36M 29.53M 26.9M 50.43M 3.45B 50.49M 354M 136M 1.76B 135M 132M 5.66B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
21/09/26 NT$134.00 0.00% 86,167
18/09/26 NT$134.00 -0.37% 120,978
17/09/26 NT$134.50 +0.75% 115,528
16/09/26 NT$133.50 +0.38% 77,030
15/09/26 NT$133.00 -0.75% 106,800
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
134.00TWD
Average target price
150.00TWD
Spread / Average Target
+11.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!